Is the price fair?
What IOSP's price assumes
Innospec Inc. trades at 20.8× earnings against 28.3× for the median Specialty Chemicals name, cheaper than its own group.
20.8
Trailing P/E · Specialty Chemicals median 28.3 · cheaper than the typical name in its group
- Price / sales
- 1.00
Price / sales · as of 2026-Q1
- Free cash flow yield
- 3.8%
Free cash flow yield · Specialty Chemicals median 3.9%
- Growth the price implies
- +9.4%
Growth the price implies · The price pays for +9.4% free cash flow growth a year for a decade; the business has delivered −2.8% a year over the last three.
Details›
- Price / book2026-Q1
- 1.33
- Basic Materials median P/E153 names
- 22.8
- Specialty Chemicals median P/E37 names
- 28.3
- Free cash flow, trailing twelve months
- $77M
- Market capitalisation
- $2.04B
- 3-year revenue growth
- −3.6%
- 3-year free cash flow growth
- −2.8%
| Method | Per share |
|---|---|
| Its own P/E history, lower quartile | $87.16 |
| Its own P/E history, median | $94.83 |
| Its own P/E history, upper quartile | $119.50 |
| 52-week range | $65.12 – $95.62 |
| Today | $95.62 |
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.
Specialty Chemicals
Ranks #35 of 36 by Smart Score